NCT06134375 2026-03-12
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Dartmouth-Hitchcock Medical Center
Phase 1/2 Recruiting
Clinical Trials
7 trialsNCT00195091 2025-05-16
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
NCT00560495 2022-10-03
Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT01837329 2019-07-19
Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer
University of Rochester
Phase 1 Completed
NCT00176800 2016-08-22
Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00150995 2015-01-21
Tetrathiomolybdate in Hormone Refractory Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00176774 2012-02-07
Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma
University of Michigan Rogel Cancer Center
Phase 2 Completed